BlackRock Portfolio holdings
AUM $5.23T
1-Year Return
24.48%
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
This Quarter Return
+0.42%
1 Year Return
+24.48%
3 Year Return
+103%
5 Year Return
+187.44%
10 Year Return
+430.33%
AUM
$3.54T
AUM Growth
-$26.8B
(-0.75%)
Cap. Flow
+$3.88B
Cap. Flow
% of AUM
0.11%
Top 10 Holdings %
Top 10 Hldgs %
19.15%
Holding
5,729
New
258
Increased
2,183
Reduced
2,656
Closed
133
Top Buys
| 1 |
Moderna
MRNA
|
+$2.88B |
| 2 |
Analog Devices
ADI
|
+$2.38B |
| 3 |
Amazon
AMZN
|
+$1.91B |
| 4 |
Tesla
TSLA
|
+$1.84B |
| 5 |
Snowflake
SNOW
|
+$1.68B |
Top Sells
| 1 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
+$3.21B |
| 2 |
MXIM
Maxim Integrated Products
MXIM
|
+$2.54B |
| 3 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$1.28B |
| 4 |
WORK
Slack Technologies, Inc.
WORK
|
+$1.15B |
| 5 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$1.12B |
Sector Composition
| 1 | Technology | 23.33% |
| 2 | Healthcare | 13.79% |
| 3 | Financials | 13.24% |
| 4 | Consumer Discretionary | 11.23% |
| 5 | Communication Services | 8.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CURO
3126
DELISTED
CURO Group Holdings Corp.
CURO
| $23.1M | ﹤0.01% |
1,332,633
-5,850
| -0.4% | -$101K |
|
3127
Integral Ad Science
IAS
$1.39B
| $23M | ﹤0.01% |
1,116,862
+866,862
| +347% | +$17.9M |
|
3128
BCE
BCE
$21.7B
| $23M | ﹤0.01% |
459,672
+24,783
| +6% | +$1.24M |
|
3129
Acacia Research
ACTG
$327M
| $23M | ﹤0.01% |
3,386,944
-9,431
| -0.3% | -$64K |
|
3130
Cogent Biosciences
COGT
$1.75B
| $23M | ﹤0.01% |
2,732,235
+54,847
| +2% | +$461K |
|
|
STXB
3131
DELISTED
Spirit of Texas Bancshares, Inc. Common Stock
STXB
| $22.9M | ﹤0.01% |
947,352
-10,906
| -1% | -$264K |
|
3132
Blue Bird Corp
BLBD
$1.84B
| $22.8M | ﹤0.01% |
1,093,813
-12,240
| -1% | -$255K |
|
|
FFAI
3133
Faraday Future Intelligent Electric Inc. Common Stock
FFAI
$253M
| $22.7M | ﹤0.01% |
+251
| New | +$22.7M |
|
3134
Rocky Brands
RCKY
$217M
| $22.7M | ﹤0.01% |
477,737
-18,717
| -4% | -$891K |
|
3135
Kezar Life Sciences
KZR
$27.7M
| $22.7M | ﹤0.01% |
263,182
+3,202
| +1% | +$277K |
|
3136
CNB Financial Corp
CCNE
$750M
| $22.7M | ﹤0.01% |
933,793
-40,182
| -4% | -$978K |
|
3137
Prelude Therapeutics
PRLD
$60.6M
| $22.7M | ﹤0.01% |
725,962
+23,120
| +3% | +$722K |
|
3138
Zymeworks
ZYME
$1.21B
| $22.6M | ﹤0.01% |
778,299
-193,434
| -20% | -$5.62M |
|
3139
Korro Bio
KRRO
$294M
| $22.5M | ﹤0.01% |
63,837
+2,422
| +4% | +$855K |
|
3140
Kodak
KODK
$485M
| $22.5M | ﹤0.01% |
3,308,191
+46,052
| +1% | +$314K |
|
|
IMGO
3141
DELISTED
Imago BioSciences, Inc. Common stock
IMGO
| $22.5M | ﹤0.01% |
+1,124,493
| New | +$22.5M |
|
3142
NWPX Infrastructure, Inc. Common Stock
NWPX
$503M
| $22.5M | ﹤0.01% |
949,714
+45,882
| +5% | +$1.09M |
|
|
OLK
3143
DELISTED
Olink Holding AB (publ) American Depositary Shares
OLK
| $22.5M | ﹤0.01% |
928,016
-128,300
| -12% | -$3.11M |
|
3144
iShares Core MSCI Europe ETF
IEUR
$6.89B
| $22.5M | ﹤0.01% |
401,175
+55,610
| +16% | +$3.12M |
|
3145
Puma Biotechnology
PBYI
$231M
| $22.5M | ﹤0.01% |
3,207,661
+141,897
| +5% | +$995K |
|
|
EGIO
3146
DELISTED
Edgio, Inc. Common Stock
EGIO
| $22.5M | ﹤0.01% |
236,141
-8,057
| -3% | -$767K |
|
3147
AXT Inc
AXTI
$184M
| $22.4M | ﹤0.01% |
2,688,757
-104,894
| -4% | -$874K |
|
3148
Lexicon Pharmaceuticals
LXRX
$400M
| $22.4M | ﹤0.01% |
4,650,670
+3,811
| +0.1% | +$18.3K |
|
|
KVSA
3149
DELISTED
Khosla Ventures Acquisition Co. Class A Common Stock
KVSA
| $22.3M | ﹤0.01% |
2,259,644
| – | – |
|
|
RXDX
3150
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
| $22.3M | ﹤0.01% |
940,120
+942
| +0.1% | +$22.3K |
|